These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 35477466

  • 21. A double-blinded, randomized, methylprednisolone-controlled study on the efficacy of oclacitinib in the management of pruritus in cats with nonflea nonfood-induced hypersensitivity dermatitis.
    Noli C, Matricoti I, Schievano C.
    Vet Dermatol; 2019 Apr; 30(2):110-e30. PubMed ID: 30656750
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of oclacitinib for the control of feline atopic skin syndrome: correlating plasma concentrations with clinical response.
    Carrasco I, Ferrer L, Puigdemont A.
    J Feline Med Surg; 2022 Aug; 24(8):787-793. PubMed ID: 34612749
    [Abstract] [Full Text] [Related]

  • 23. A randomised, double-blinded, controlled trial to determine the efficacy of combined therapy of oclacitinib and marine oil extract PCSO-524 in dogs with atopic dermatitis.
    Nishiyama T, Kusakabe M, Imanishi I, Hisano T, Fukamachi T, Taguchi N, Iyori K, Hsiao YH.
    Vet Dermatol; 2023 Dec; 34(6):523-531. PubMed ID: 37485602
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Describing the antimicrobial usage patterns of companion animal veterinary practices; free text analysis of more than 4.4 million consultation records.
    Hur BA, Hardefeldt LY, Verspoor KM, Baldwin T, Gilkerson JR.
    PLoS One; 2020 Dec; 15(3):e0230049. PubMed ID: 32168354
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Oclacitinib in feline nonflea-, nonfood-induced hypersensitivity dermatitis: results of a small prospective pilot study of client-owned cats.
    Ortalda C, Noli C, Colombo S, Borio S.
    Vet Dermatol; 2015 Aug; 26(4):235-e52. PubMed ID: 25940959
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. An update on the treatment of canine atopic dermatitis.
    Saridomichelakis MN, Olivry T.
    Vet J; 2016 Jan; 207():29-37. PubMed ID: 26586215
    [Abstract] [Full Text] [Related]

  • 30. IL-31-induced pruritus in dogs: a novel experimental model to evaluate anti-pruritic effects of canine therapeutics.
    Gonzales AJ, Fleck TJ, Humphrey WR, Galvan BA, Aleo MM, Mahabir SP, Tena JK, Greenwood KG, McCall RB.
    Vet Dermatol; 2016 Feb; 27(1):34-e10. PubMed ID: 26666963
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ear tip ulcerative dermatitis treated with oclacitinib in 25 dogs: a retrospective case series.
    Colombo S, Cornegliani L, Vercelli A, Fondati A.
    Vet Dermatol; 2021 Aug; 32(4):363-e100. PubMed ID: 34250688
    [Abstract] [Full Text] [Related]

  • 33. A retrospective analysis of the use of lokivetmab in the management of allergic pruritus in a referral population of 135 dogs in the western USA.
    Souza CP, Rosychuk RAW, Contreras ET, Schissler JR, Simpson AC.
    Vet Dermatol; 2018 Dec; 29(6):489-e164. PubMed ID: 30141223
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Long-term effects of ciclosporin and oclacitinib on mediators of tolerance, regulatory T-cells, IL-10 and TGF-β, in dogs with atopic dermatitis.
    Herrmann I, Mamo LB, Holmes J, Mohammed JP, Murphy KM, Bizikova P.
    Vet Dermatol; 2023 Apr; 34(2):107-114. PubMed ID: 36482868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.